For the Inventor, By the Inventor

Enter inventor name

Schenectady, NY, United States of America

Ruifang Wang

This inventor holds 15 USPTO granted patents, plus 2 CIPO patents and 6 EPO patents. Top assignee: Zenith Epigenetics Corp.. Active years: 2016-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ruifang Wang. Retrieved from https://idiyas.com/inventor/ruifang-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15

% Patents Active = 33.3

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 8.6

ph-index = 7

Forward Citations = 139(Granted Patents)

Company Filing History:

Zenith Epigenetics Corp.

Years Active: 2016-2022

Loading Chart...

Loading Chart...

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11446306 - Bicyclic bromodomain inhibitors (2022-09-20),

2. 11026926 - Substituted bicyclic compounds as bromodomain inhibitors (2021-06-08),

3. 10772892 - Bicyclic bromodomain inhibitors (2020-09-15),

4. 10710992 - Substituted pyridinones as bromodomain inhibitors (2020-07-14),

5. 10363257 - Bicyclic bromodomain inhibitors (2019-07-30),

6. 10226451 - Substituted bicyclic compounds as bromodomain inhibitors (2019-03-12),

7. 10179125 - Substituted pyridines as bromodomain inhibitors (2019-01-15),

8. 10166215 - Substituted bicyclic compounds as bromodomain inhibitors (2019-01-01),

9. 10010556 - Bicyclic bromodomain inhibitors (2018-07-03),

10. 9861637 - Heterocyclic compounds as bromodomain inhibitors (2018-01-09),

11. 9663520 - Bicyclic bromodomain inhibitors (2017-05-30),

12. 9662311 - Substituted bicyclic compounds as bromodomain inhibitors (2017-05-30),

13. 9636328 - Substituted bicyclic compounds as bromodomain inhibitors (2017-05-02),

14. 9598367 - Heterocyclic compounds as bromodomain inhibitors (2017-03-21),

15. 9271978 - Heterocyclic compounds as bromodomain inhibitors (2016-03-01),

Title: Innovator Spotlight: Ruifang Wang

Introduction: Ruifang Wang is a prominent inventor based in Schenectady, NY. With an impressive portfolio of 15 patents, Wang has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that target specific protein functions.

Latest Patents: Among his latest patents, Wang is recognized for the inventions related to bicyclic bromodomain inhibitors. These inventions involve substituted bicyclic compounds that are instrumental in inhibiting BET protein function by binding to bromodomains. Furthermore, these patents also encompass pharmaceutical compositions containing these compounds and their therapeutic applications.

Career Highlights: Wang's work at Zenith Epigenetics Corp. underscores his commitment to advancing medical science and innovation. His background in pharmaceutical development has been pivotal in creating solutions that may lead to breakthroughs in therapies for various conditions, including cancer.

Collaborations: Throughout his career, Wang has worked alongside notable colleagues such as Shuang Liu and Bryan Cordell Duffy. These collaborations have enabled him to combine expertise and drive forward his innovative projects in pharmacology.

Conclusion: Ruifang Wang stands out as an inventive force within the pharmaceutical industry. His contributions through his patents are not only advancing medical research but also paving the way for new therapeutic opportunities. As he continues his work at Zenith Epigenetics Corp., the impact of his innovations will likely resonate within healthcare for years to come.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…